Avinger, Inc.: Avinger Provides Update on Tigereye Commercial Launch
REDWOOD CITY, CA / ACCESSWIRE / April 8, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today provided an update on the commercial launch of Tigereye CTO Crossing catheters for the treatment of PAD.
Following limited launch in the fourth quarter of 2020, Avinger initiated full commercial launch of Tigereye in January 2021. Tigereye has now been launched in 30 clinical sites with more than 160 cases successfully performed. Avinger territory sales managers have opened an average of 2.7 sites per person since launch. Tigereye revenue is expected to drive an approximately 60% increase in Avinger s combined Lumivascular CTO revenue for the first quarter of 2021 compared to the year-ago period.
Avinger Provides Update on Tigereye(TM) Commercial Launch
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Avinger Provides Update on Tigereye(TM) Commercial Launch
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Cipherloc Announces $6 4 Million Offering of Common Stock
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.